Mostrando 8 resultados de: 8
Publisher
British Journal of Clinical Pharmacology(1)
Clinical Pharmacology and Therapeutics(1)
Clinical neuropharmacology(1)
European Journal of Clinical Pharmacology(1)
Nordic Journal of Psychiatry(1)
Área temáticas
Farmacología y terapéutica(5)
Enfermedades(4)
Bioquímica(2)
Medicina y salud(2)
Problemas sociales y servicios a grupos(2)
Objetivos de Desarrollo Sostenible
ODS 3: Salud y bienestar(8)
ODS 10: Reducción de las desigualdades(3)
ODS 12: Producción y consumo responsables(2)
ODS 9: Industria, innovación e infraestructura(2)
ODS 5: Igualdad de género(1)
Origen
scopus(8)
Antibiotic use in 3 European university hospitals
ArticleAbstract: The use of antibiotic drugs was studied in university teaching hospitals in Tartu, Estonia, HuddingePalabras claves:Autores:Adrián LLerena, Berecz R., Dahl M.L., Kiivet R.A., Maimets M., Wettermark B.Fuentes:scopusCYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteers
ArticleAbstract: Objective: This study analyzed the frequency of CYP2C9 variant alleles and evaluated the impact of CPalabras claves:CYP2C9, Diclofenac, GenotypingAutores:Adrián LLerena, Berecz R., Dahl M.L., Dorado P., Norberto M., Yasar U.Fuentes:scopusAn Appeal to the Global Health Community for a Tripartite Innovation: An "essential Diagnostics List," "health in All Policies," and "see-Through 21<sup>st</sup> Century Science and Ethics"
ReviewAbstract: Diagnostics spanning a wide range of new biotechnologies, including proteomics, metabolomics, and naPalabras claves:Autores:Adrián LLerena, Barlas Ö., Birch K., Boehme C., Borda-Rodriguez A., Byne W.M., Chaverneff F., Coşkun Y., Dahl M.L., Dereli T., Diwakar S., Dove E.S., Elbeyli L., Endrenyi L., Eroʇlu-Kesim B., Ferguson L.R., Güngör K., Gürsoy U.K., Hekim N., Huzair F., Kaushik K., Kickbusch I., Klroʇlu O., Kolker E., Könönen E., Lin B., Malhan F., Nair B., Özdemir V., Patrinos G.P., Sardaş S., Sert Ö., Srivastava S., Steuten L.M.G., Toraman C., Vayena E., Wang W., Warnich L.Fuentes:scopusGenetic factors in the metabolism of haloperidol.
ArticleAbstract:Palabras claves:Autores:Adrián LLerena, Bertilsson L., Dahl M.L., Ekqvist B.Fuentes:scopusHaloperidol disposition is dependent on the debrisoquine hydroxylation phenotype: Increased plasma levels of the reduced metabolite in poor metabolizers
ArticleAbstract: We have previously shown that the disposition of haloperidol is decreased in poor (PM) compared to ePalabras claves:debrisoquine, humans, pharmacogenetics, Reduced haloperidolAutores:Adrián LLerena, Bertilsson L., Dahl M.L., Ekqvist B.Fuentes:scopusPatterns of drug treatment of schizophrenic patients in Estonia, Spain and Sweden.
ArticleAbstract: 1. Patterns of drug treatment and the use of polypharmacy in schizophrenic in‐patients were comparedPalabras claves:Autores:Adrián LLerena, Dahl M.L., Eklundh T., Kiivet R.A., Rootslane L., Sanchez Vega J., Sjoqvist F.Fuentes:scopusPharmacokinetics of losartan and its metabolite E-3174 in relation to the CYP2C9 genotype
ArticleAbstract: Background and aim: Losartan is metabolized by polymorphic CYP2C9 to E-3174. Our aim was to evaluatePalabras claves:Autores:Adrián LLerena, Dahl M.L., Dorado P., Eliasson E., Forslund-Bergengren C., Sjoqvist F., Tybring G., Yasar U.Fuentes:scopusPsychotropic drug use in non-psychiatric departments of three European university hospitals
ArticleAbstract: The use of psychotropic drugs in the university hospitals in Tartu, Estonia; Huddinge, Sweden; and BPalabras claves:drug utilization, psychotropic drugsAutores:Adrián LLerena, Dahl M.L., Kiivet R.A., Rootslane L., Sanchez Vega J., Wettermark B.Fuentes:scopus